Korsana Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Korsana Biosciences (KRSA).

Price Target Range — 2 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$53Upside to Avg. PT+75.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 5, 2026	Wedbush	Laura Chico	Initiate	Outperform	$44
Sep 28, 2026	Guggenheim	Yatin Suneja	Initiate	Buy	$70
Sep 14, 2026	Stifel	Paul Matteis	Initiate	Buy	$43
Sep 14, 2026	TD Cowen	Tyler Van Buren	Initiate	Buy	—
Sep 11, 2026	UBS	Michael Yee	Initiate	Buy	$55

Analyst Ratings News

PRO
Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44

Wedbush analyst Laura Chico initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Outperform rating and announces Price Target of $44.

Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $70

Guggenheim analyst Yatin Suneja initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $70.

Benzinga Newsdesk

PRO
Stifel Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $43

Stifel analyst Paul Matteis initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $43.

Benzinga Newsdesk

PRO
TD Cowen Initiates Coverage On Korsana Biosciences with Buy Rating

TD Cowen analyst Tyler Van Buren initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating.

Benzinga Newsdesk

PRO
UBS Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $55

UBS analyst Michael Yee initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $55.

Benzinga Newsdesk

Korsana Biosciences Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Korsana Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44

PRO
Guggenheim Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $70

PRO
Stifel Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $43

PRO
TD Cowen Initiates Coverage On Korsana Biosciences with Buy Rating

PRO
UBS Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $55

People Also Watch

People Also Watch

Korsana Biosciences Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Korsana Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44

PROGuggenheim Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $70

PROStifel Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $43

PROTD Cowen Initiates Coverage On Korsana Biosciences with Buy Rating

PROUBS Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $55

People Also Watch

People Also Watch

PRO
Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44

PRO
Guggenheim Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $70

PRO
Stifel Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $43

PRO
TD Cowen Initiates Coverage On Korsana Biosciences with Buy Rating

PRO
UBS Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $55